3
SUMMARY
PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal
The company raked in a total of INR 667.7 Cr share via the block deal, which valued each share at INR 1,252.03
Following this transaction, PharmEasy’s ownership in Thyrocare will reduce to 60.93% from the 70.98% stake it held previously
Distressed healthtech startup PharmEasy’s subsidiary Docon Technologies has offloaded…
